Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent

BACKGROUND/AIMS: To evaluate the impact on mortality of anti-tumor necrosis factor (anti-TNF) treatment of rheumatoid arthritis-associated interstitial lung disease (RA-ILD). METHODS: We retrospectively reviewed the medical records of 100 RA-ILD patients who visited our tertiary care medical center...

Descripción completa

Detalles Bibliográficos
Autores principales: Koo, Bon San, Hong, Seokchan, Kim, You Jae, Kim, Yong-Gil, Lee, Chang-Keun, Yoo, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293548/
https://www.ncbi.nlm.nih.gov/pubmed/25589842
http://dx.doi.org/10.3904/kjim.2015.30.1.104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293548/
https://www.ncbi.nlm.nih.gov/pubmed/25589842
http://dx.doi.org/10.3904/kjim.2015.30.1.104

Ejemplares similares